Related Experiment Video
Updated: Jul 17, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Primitive metastasizing bronchial carcinoid with long survival].
N Bouvier1, V Zengerling, A Halley
1Service de Pneumologie, CHU Côte de Nacre, Caen, France.
Revue Des Maladies Respiratoires
|February 3, 2007
Summary
Metastatic bronchial carcinoid tumors, though rare, can have prolonged survival. Advanced imaging like positron-emission tomography and pentetreotide SPECT aids in assessing disease extent, improving patient outcomes.
Area of Science:
- Oncology
- Nuclear Medicine
Background:
- Metastatic bronchial carcinoid tumors are rare neuroendocrine neoplasms.
- Prolonged survival is observed in some patients with these tumors.
- Functional imaging techniques enhance disease extent assessment.
Observation:
- A 57-year-old patient presented with dyspnea and carcinoid syndrome.
- Positron-emission tomography and pentetreotide SPECT revealed liver and bone metastases.
- Treatment included lobectomy, somatostatin analogues, and chemoembolization, with survival exceeding 44 months.
Findings:
- Histological type is a key prognostic factor for metastatic bronchial carcinoid tumors.
- Carcinoid syndrome suggests the presence of these tumors.
- New functional imaging modalities significantly aid in evaluating extra-thoracic disease spread.
Implications:
- Despite limited chemotherapy options, symptomatic management can prolong survival.
- Advanced imaging improves the staging and management of metastatic bronchial carcinoid tumors.
- Multimetastatic patients can achieve extended survival with appropriate interventions.
